Aprea Therapeutics, Inc.
$0.84
-0.02 (-2.50%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +32.1%
- 3 Months
- -6.0%
- YTD
- -1.7%
- 1 Year
- -47.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 92.7%
- Largest decline max drawdown, since Aug 2025
- -65.1%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.25
Own APRE?
See how APRE contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.